RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Deltex Medical Group - Stock

Deltex Medical Group Stocks 2024

Deltex Medical Group Stocks

1.18 B

Ticker

DEMG.L

ISIN

GB0059337583

WKN

927020

In 2024, Deltex Medical Group had 1.18 B outstanding stocks, a 72.32% change from the 685.49 M stocks in the previous year.

The Deltex Medical Group Stocks history

YEARNUMBER OF STOCKS (undefined GBP)
20231.18
20220.69
20210.58
20200.53
20190.47
20180.47
20170.3
20160.27
20150.22
20140.2
20130.16
20120.15
20110.14
20100.13
20090.11
20080.1
20070.09
20060.08
20050.07
20040.06

Deltex Medical Group shares outstanding

The number of shares was Deltex Medical Group in 2023 — This indicates how many shares 1.181 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Deltex Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Deltex Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Deltex Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Deltex Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Deltex Medical Group Aktienanalyse

What does Deltex Medical Group do?

Deltex Medical Group PLC is a leading provider of anesthesia, intensive care, and emergency medicine monitoring products. The company develops and produces products for patient monitoring during anesthesia and cardiovascular system monitoring. Additionally, Delta Medical offers training for healthcare professionals. The company specializes in developing and producing products that enable real-time monitoring of blood flow and fluid volume. These products are primarily designed for use in anesthesia, intensive care, and emergency medicine. The technology allows medical professionals to improve both patient care and process efficiency. Deltex Medical operates in the anesthesia, intensive care, and emergency medicine industries. Each industry has specific patient monitoring requirements, and Deltex Medical offers specialized products for each area. For example, anesthesia products focus on monitoring fluid volume and blood flow during anesthesia. Intensive care products continuously measure fluid volume and blood flow in patients with severe illnesses or injuries. Deltex Medical's emergency medicine products enable rapid patient monitoring in acute medical situations. Some of Deltex Medical's products include the CardioQ-ODM+ and the TrueVue system for monitoring cardiovascular functions and vital signs. The CardioQ-ODM+ is a non-invasive system designed for anesthesia, intensive care, and emergency medicine patients. The TrueVue system is an invasive system used during surgeries and in intensive care to monitor blood flow and fluid volume in real-time. Both systems provide real-time data that allows for quick and accurate adjustments to patient care. Deltex Medical also offers training for healthcare professionals to ensure optimal use of the systems. The training is aimed at anesthesiologists, intensivists, and emergency medicine physicians, covering both theory and practical application of the systems. The training can be conducted online or in-person. In 2011, Deltex Medical received a significant award for its work in anesthesia monitoring. The Technology Industry Award praised the company for its continuous innovation and mission to improve clinical practice. In summary, Deltex Medical Group PLC is a leading provider of anesthesia, intensive care, and emergency medicine monitoring products. The company has a wide product portfolio that includes both invasive and non-invasive systems. Additionally, Deltex Medical offers training to ensure optimal use of the systems by healthcare professionals. With its technical expertise and commitment to clinical practice, Deltex Medical Group PLC has become a valuable partner in the healthcare industry. Deltex Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Deltex Medical Group's Shares Outstanding

Deltex Medical Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Deltex Medical Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Deltex Medical Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Deltex Medical Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Deltex Medical Group Stock

How many stocks are there of Deltex Medical Group?

The current number of stocks of Deltex Medical Group is 1.18 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Deltex Medical Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Deltex Medical Group evolved in recent years?

The number of shares of Deltex Medical Group has increased by 72.32% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Deltex Medical Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Deltex Medical Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Deltex Medical Group pay?

Over the past 12 months, Deltex Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deltex Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Deltex Medical Group?

The current dividend yield of Deltex Medical Group is .

When does Deltex Medical Group pay dividends?

Deltex Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deltex Medical Group?

Deltex Medical Group paid dividends every year for the past 0 years.

What is the dividend of Deltex Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deltex Medical Group located?

Deltex Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Deltex Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deltex Medical Group from 6/28/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 6/28/2024.

When did Deltex Medical Group pay the last dividend?

The last dividend was paid out on 6/28/2024.

What was the dividend of Deltex Medical Group in the year 2023?

In the year 2023, Deltex Medical Group distributed 0 GBP as dividends.

In which currency does Deltex Medical Group pay out the dividend?

The dividends of Deltex Medical Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Deltex Medical Group

Our stock analysis for Deltex Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deltex Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.